Clinical Trials
- Arthritis
Yale Rheumatology Program Patient Registry and Bio-Repository
- Ages18 years - 99 years
- GenderBoth
- Date05/11/2020
- Children's Health, Immune System, Arthritis
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Ages2 years - 21 years
- GenderBoth
- Date07/25/2018
- Immune System
Yale Lupus and Connective Tissue Disease Bio-Repository / Yale Rheumatology Bio-Repository
- Ages18 years and older
- GenderBoth
- Date10/01/2016
- Orthopaedics, Muscle & Bone
Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis (RAISE-XT)
- Ages40 years - 80 years
- GenderBoth
- Date07/01/2020
- Immune System
Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE)
- Ages18 years - 75 years
- GenderBoth
- Date04/27/2021
- Orthopaedics, Muscle & Bone, Immune System
Nature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLE (NAIVE)
- Ages18 years - 70 years
- GenderBoth
- Date10/08/2021
- Orthopaedics, Muscle & Bone
Healthy Volunteers Needed for Hand and Heart Imaging Study
- Ages18 years and older
- GenderBoth
- Date01/26/2022
- Orthopaedics, Muscle & Bone
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus (PHOENYCS GO)
- Ages16 years and older
- GenderBoth
- Date03/25/2022
- Orthopaedics, Muscle & Bone
A Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
- Ages18 years - 80 years
- GenderBoth
- Date10/01/2021
- Orthopaedics, Muscle & Bone
Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Diffuse Cutaneous Systemic Sclerosis
- Ages18 years - 75 years
- GenderBoth
- Date12/15/2021